Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints.
Rev Inst Med Trop Sao Paulo 2015;
56:477-82. [PMID:
25351540 PMCID:
PMC4296866 DOI:
10.1590/s0036-46652014000600004]
[Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2013] [Accepted: 04/22/2014] [Indexed: 12/16/2022] Open
Abstract
The high mortality rates associated with candidemia episodes and the
emergence of resistance to antifungal agents necessitate the monitoring of the
susceptibility of fungal isolates to antifungal treatments. The new, recently
approved, species-specific clinical breakpoints
(SS-CBPs)(M27-S4) for evaluating susceptibility require
careful interpretation and comparison with the former proposals made using the
M27-A3 breakpoints, both from CLSI. This study evaluated the susceptibility of
the different species of Candida that were isolated from
candidemias based on these two clinical breakpoints. Four hundred and twenty-two
isolates were identified and, among them, C. parapsilosis
comprised 46.68%, followed by C. albicans
(35.78%), C. tropicalis (9.71%),
C. glabrata (3.55%), C.
lusitaniae (1.65%), C.
guilliermondii (1.65%) and C.
krusei (0.94%). In accordance with the M27-A3
criteria, 33 (7.81%) non-susceptible isolates were identified, of
which 16 (3.79%) were resistant to antifungal agents. According
to SS-CBPs, 80 (18.95%) isolates were non-susceptible, and 10
(2.36%) of these were drug resistant. When the total number of
non-susceptible isolates was considered, the new SS-CBPs detected 2.4 times the
number of isolates that were detected using the M27-A3 interpretative criteria.
In conclusion, the detection of an elevated number of non-susceptible species
has highlighted the relevance of evaluating susceptibility tests using new,
species-specific clinical breakpoints (SS-CBPs), which could impact
the profile of non-susceptible Candida spp. to antifungal
agents that require continuous susceptibility monitoring.
Collapse